- Accueil >
- Publications >
- Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model
Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model
Auteurs
Yushi Qiu, Zhimin Li, Frederic Pouzoulet, Prakash Vishnu, John A. Copland, Keith L. Knutson, Carole Soussain, Han W. Tun
Membres
